Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.64 - $210.12 $1.42 Million - $1.83 Million
8,700 New
8,700 $1.69 Million
Q1 2023

May 12, 2023

SELL
$220.43 - $278.69 $69.6 Million - $88 Million
-315,800 Reduced 99.75%
800 $222,000
Q4 2022

Feb 10, 2023

BUY
$151.88 - $228.5 $10.1 Million - $15.2 Million
66,600 Added 26.64%
316,600 $70.4 Million
Q3 2022

Nov 14, 2022

BUY
$120.36 - $205.88 $30.1 Million - $51.5 Million
250,000 New
250,000 $47.4 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.43B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.